Human ELABELA ELISA Kit (DEIA-XYZ71)

Regulatory status: For research use only, not for use in diagnostic procedures.

Write a review

Size
96T
Sample
blood, plasma
Species Reactivity
Human
Intended Use
This Enzyme Immunoassay kit is designed to detect a specific peptide and its related peptides based on the principle of "competitive" enzyme immunoassay.
Storage
1. Store the kit at 4°C upon receipt.
2. It is highly recommended that solutions be used as soon as possible after rehydration.
3. Store 1x assay buffer at 4°C.
4. Remove any unneeded strips from antibody-coated plate, reseal them in zip-lock foil and keep at 4°C.
5. Keep rehydrated solution of Standard, Biotinylated peptide, Antibody and SA-HRP at 4°C.
Precision
Intra-assay Precision (Precision within an assay): CV%<10%
Inter-assay Precision (Precision between assays): CV%<15%
Detection Range
0-100 ng/ml
Sensitivity
0.20 ng/ml
General Description
ELABELA (ELA) is a novel hormone consisting of 32 amino acid peptides found in humans as well as other vertebrates and is considered to play an important role in the circulatory system through the apelin receptor (APJ). However, whether ELA also acts in the central nervous system remains unknown. ELA functions as an anorexigenic hormone in adult mouse brain. An intracerebroventricular injection of ELA reduces food intake and activates arginine vasopressin (AVP) and corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus (PVN), a hypothalamic region that regulates food intake. Cytosolic calcium ([Ca]i) measurement shows that ELA dose dependently increases [Ca]i in single AVP and CRH-immunoreactive neurons isolated from the PVN.

Citations


Have you cited DEIA-XYZ71 in a publication? Let us know and earn a reward for your research.

Related Products


Customer Reviews


Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

Villie, Patricia, et al. "ELABELA concentration is not decreased in maternal plasma before the onset of preeclampsia." American Journal of Obstetrics & Gynecology 220.3 (2019): 284-285.

Have you cited DEIA-XYZ71 in a publication? Let us know and earn a reward for your research.

Online Inquiry

Name:
Phone: *
E-mail Address: *
Service & Products Interested: *
Project Description:
Verification Code: * Please input "diagnostics" as verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket